Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.

Matera, L; Bellone, G; Lebren, J J; Kelly, P A; Hooghe Peters, E L; Di Celle, P F; Foa, R; Contarini, M; Avanzi, G; Asnaghi, V

Matera, L; Bellone, G; Lebren, J J; Kelly, P A; Hooghe Peters, E L; Di Celle, P F; Foa, R; Contarini, M; Avanzi, G; Asnaghi, V.

Affiliation

Matera L; Institute of Internal Medicine, Turin, Italy.

Immunology ; 89(4): 619-26, 1996 Dec.

Article in En | MEDLINE | ID: mdl-9014831

Subject(s)

Interleukin-2/pharmacology; Killer Cells, Lymphokine-Activated/drug effects; Prolactin/pharmacology; Cell Differentiation/drug effects; Cells, Cultured; Humans; Immunohistochemistry; In Situ Hybridization; Killer Cells, Lymphokine-Activated/cytology; Killer Cells, Natural/cytology; Killer Cells, Natural/drug effects; Polymerase Chain Reaction

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Prolactin / Killer Cells, Lymphokine-Activated / Interleukin-2 Limits: Humans Language: En Year: 1996 Type: Article

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Prolactin / Killer Cells, Lymphokine-Activated / Interleukin-2 Limits: Humans Language: En Year: 1996 Type: Article